Each year, roughly 65,000 myomectomies are performed in the United States to treat uterine fibroids – benign (non-cancerous) tumors occurring in at least one quarter of all women. They can grow underneath the uterine lining, inside the uterine wall or outside the uterus.
The conventional approach to myomectomy is open surgery, through a large abdominal incision to access the uterus and surrounding anatomy. Open surgery can cause significant pain, physical trauma and a long recovery process. While myomectomy surgery is also performed laparoscopically, this approach can be challenging for the surgeon, and may compromise results compared to open surgery. Laparoscopic myomectomy surgery often takes longer than open abdominal myomectomies, and up to 28% are converted during surgery to an open abdominal incision.
Robotic Myomectomy Means Less Pain, Faster Recovery
A new category of minimally invasive myomectomy surgery combines the best of open and laparoscopic surgery. With the assistance of the da Vinci® Surgical System – the latest evolution in robotics technology – Chilton Medical Center's gynecologic surgeons may remove uterine fibroids through small incisions with unmatched precision and control.
For robotic myomectomy patients, that means a host of potential benefits, including:
- Shorter hospital stay (one day in most cases, versus 3-5)
- Significantly less pain post-operatively (often only over-the-counter pain meds required)
- Quicker recovery and return to normal activities (1-2 weeks, versus 6-8 weeks)
- Fewer complications and less risk of infection
- Less scarring (small, dime-sized incisions, versus 6-8 inch scar
Are You a Candidate for Robotic Myomectomy?
To find out if a minimally invasive robotic gynecologic procedure is right for you, see our online physician directory or call 1-888-CHILTON.
Our Medical Team
Khashayar Shakiba, MD
Steven Domnitz, MD
Shaghayegh DeNoble, MD